Search

Your search keyword '"Edward M. Messing"' showing total 532 results

Search Constraints

Start Over You searched for: Author "Edward M. Messing" Remove constraint Author: "Edward M. Messing"
532 results on '"Edward M. Messing"'

Search Results

101. MP53-07 PREDICTORS OF IPSILATERAL EXTRAPROSTATIC EXTENSION ON RADICAL PROSTATECTOMY USING 3-TESLA MULTIPARAMETRIC MRI AND CONTEMPORARY PATHOLOGIC FEATURES

102. Molecular Landscape of Non-Muscle Invasive Bladder Cancer

103. Bladder Cancer Extracellular Vesicles Drive Tumorigenesis by Inducing Endoplasmic Reticulum Stress

104. The conundrum of recurrent low-grade tumours: to treat or to observe?

106. Characterization of the Host Immuno-Inflammatory State in Response to Radiation Therapy and Correlation with Patient Reported Toxicities In Prostate Adenocarcinoma, A Prospective Observational Trial

107. Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression

108. Beyond Cisplatin – I

110. Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals

111. Rate of Symptomatic Lymphocele Formation After Extraperitoneal vs Transperitoneal Robot-Assisted Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy

112. Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial

113. A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens

114. The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory

115. Reduced estimated glomerular filtration rate (eGFR60 mL/min/1.73 m

116. Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy

117. PNFLBA-10 A PHASE III BLINDED STUDY OF IMMEDIATE POST-TURBT INSTILLATION OF GEMCITABINE VERSUS SALINE IN PATIENTS WITH NEWLY DIAGNOSED OR OCCASIONALLY RECURRING GRADE I/II NON-MUSCLE INVASIVE BLADDER CANCER: SWOG S0337

118. MP65-02 CANCER EXTRACELLULAR VESICLES PROMOTE BLADDER TUMORIGENESIS BY INDUCING CHRONIC ENDOPLASMIC RETICULUM STRESS AND INFLAMMATION: A NOVEL MECHANISM FOR FIELD CANCERIZATION

119. MP08-14 DEVELOPMENT AND VALIDATION OF A NOMOGRAM FOR PREDICTING PIRADS 4-5 LESIONS ON MULTIPARAMETRIC PROSTATE MRI

121. PD71-05 VALIDATION OF GEMCAP AS A DNA BASED BIOMARKER TO PREDICT PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY

122. MP87-13 ESTROGEN RECEPTOR α IN CANCER ASSOCIATED FIBROBLASTS SUPPRESSES PROSTATE CANCER INVASION VIA REDUCING CCL5, IL6 AND MACROPHAGE INFILTRATION IN THE TUMOR MICROENVIRONMENT

123. PD11-10 IMPACT OF GLEASON PATTERN 4 CRIBRIFORM ARCHITECTURE ON PROSTATE CANCER DETECTION USING MULTIPARAMETRIC MRI

125. PD05-10 ANTIBIOTIC PROPHYLAXIS PRIOR TO URINARY CATHETER REMOVAL AFTER RADICAL PROSTATECTOMY DOES NOT PREVENT URINARY TRACT INFECTIONS: A RANDOMIZED CONTROLLED CLINICAL TRIAL

126. MP65-12 TARGETING ESTROGEN/ESTROGEN RECEPTOR SIGNAL PATHWAYS TO ENHANCE THE EFFICACY OF BACILLUS CALMETTE-GUÉRIN TREATMENT IN BLADDER CANCER

127. MP03-11 INSTITUTIONAL LEARNING CURVE ASSOCIATED WITH IMPLEMENTATION OF A MR/US FUSION BIOPSY PROGRAM USING PIRADS VERSION 2: FACTORS THAT INFLUENCE SUCCESS

128. Editorial Comment

129. A More Thorough Transurethral Resection

130. Extraperitoneal vs Transperitoneal Robot-Assisted Radical Prostatectomy in the Setting of Prior Abdominal or Pelvic Surgery

131. Bladder Cancer Exosomes Contain EDIL-3/Del1 and Facilitate Cancer Progression

132. Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer

133. Overall Survival after Partial Versus Radical Nephrectomy for a Small Renal Mass: Systematic Review of Observational Studies

135. Psychological Stress and Suicide in Bladder Cancer Patients

136. A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa): Tolerability and geriatric asssessment (GA) results

137. Antibiotic prophylaxis at the time of catheter removal after radical prostatectomy: A prospective randomized clinical trial

138. Paper Alert

139. Non-bladder cancer mortality in patients with urothelial cancer of the bladder

140. Complications Associated With Extraperitoneal Robot-assisted Radical Prostatectomy Using the Standardized Martin Classification

141. Checkpoint Inhibitors for Advanced Bladder Cancer

142. Complete Remission of Locally Advanced Penile Squamous Cell Carcinoma after Multimodality Treatment

143. Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study

144. MP80-09 IS EXTRAPERITONEAL ROBOT-ASSISTED RADICAL PROSTATECTOMY CONTRAINDICATED IN THE SETTING OF PRIOR INGUINAL HERNIA REPAIR WITH MESH?

146. V8-01 FULL PROCEDURAL SIMULATION FOR TRANSURETHRAL RESECTION OF BLADDER TUMORS (TURBT) USING 3-D PRINTING TECHNOLOGY

147. MP13-12 MODERATE CHRONIC KIDNEY DISEASE (EGFR <60 ML/MIN) PREDICTS RECURRENCE AND PROGRESSION IN BLADDER CANCER PATIENTS TREATED WITH TRANSURETHRAL RESECTION

149. Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients

Catalog

Books, media, physical & digital resources